Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#412 most reported symptom for this vaccine
Blood thyroid stimulating hormone has been reported 33 times in association with Meningococcal Conjugate (Menactra) vaccination in VAERS. This represents 0.1% of all 36,149 reports for this vaccine.
Among these reports, 0 mentioned death (0.00%) and 4 involved hospitalization (12.1%).
Blood thyroid stimulating hormone is the #412 most frequently reported symptom for Meningococcal Conjugate (Menactra) out of 1843 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 33 reports of Blood thyroid stimulating hormone after Meningococcal Conjugate (Menactra) vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.00%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.